IF by specialty › Oncology
Journal of Thoracic Oncology — Impact Factor
The 2025 Impact Factor of Journal of Thoracic Oncology is 23.3 (Q1 in Oncology, Q1 in Respiratory System; subscription or hybrid).
- Impact Factor
- 23.3 JCR 2025
- JCR category
- Oncology, Respiratory System
- Quartile
- Q1 in Oncology, Q1 in Respiratory System
- Publisher
- Elsevier (IASLC)
- Open access
- subscription or hybrid
- IF source
- bioxbio.com
Position within the field
Ranked 12 of the 42 journals in Oncology on this site (top 50%).
Oncology journals with a similar Impact Factor
- Lancet Oncology IF 33.7
- Cancer Discovery IF 29.5
- Nature Cancer IF 28.0
- JAMA Oncology IF 23.9
- Cancer Research IF 22.6
- Journal for ImmunoTherapy of Cancer IF 11.7
About this value
The Journal Impact Factor of Journal of Thoracic Oncology (JCR 2025, released June 2026) is 23.3. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.